Innate Pharma Stock Price Prediction
| IPHYF Stock | USD 2.15 0.00 0.00% |
Momentum 80
Buy Stretched
Oversold | Overbought |
Using Innate Pharma hype-based prediction, you can estimate the value of Innate Pharma from the perspective of Innate Pharma response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Innate Pharma to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying Innate because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Innate Pharma after-hype prediction price | USD 2.15 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Innate |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Innate Pharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Innate Pharma After-Hype Price Density Analysis
As far as predicting the price of Innate Pharma at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Innate Pharma or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Innate Pharma, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Innate Pharma Estimiated After-Hype Price Volatility
In the context of predicting Innate Pharma's pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Innate Pharma's historical news coverage. Innate Pharma's after-hype downside and upside margins for the prediction period are 0.44 and 3.86, respectively. We have considered Innate Pharma's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Innate Pharma is relatively risky at this time. Analysis and calculation of next after-hype price of Innate Pharma is based on 3 months time horizon.
Innate Pharma Pink Sheet Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Innate Pharma is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Innate Pharma backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Innate Pharma, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.13 | 1.71 | 0.02 | 0.02 | 18 Events / Month | 5 Events / Month | In about 18 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
2.15 | 2.15 | 0.00 |
|
Innate Pharma Hype Timeline
Innate Pharma is currently traded for 2.15. The entity has historical hype elasticity of -0.02, and average elasticity to hype of competition of -0.02. Innate is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is currently at 0.13%. %. The volatility of related hype on Innate Pharma is about 1230.22%, with the expected price after the next announcement by competition of 2.13. About 23.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.48. Some equities with similar Price to Book (P/B) outperform the market in the long run. Innate Pharma recorded a loss per share of 0.69. The entity had not issued any dividends in recent years. Assuming the 90 days horizon the next anticipated press release will be in about 18 days. Check out Innate Pharma Basic Forecasting Models to cross-verify your projections. For more detail on how to invest in Innate Pink Sheet please use our How to Invest in Innate Pharma guide.Innate Pharma Related Hype Analysis
Having access to credible news sources related to Innate Pharma's direct competition is more important than ever and may enhance your ability to predict Innate Pharma's future price movements. Getting to know how Innate Pharma's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Innate Pharma may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| BXPHF | Botanix Pharmaceuticals Limited | (0.18) | 21 per month | 7.13 | 0.03 | 12.86 | (12.82) | 56.17 | |
| NDTP | NDT Pharmaceuticals | (0.18) | 3 per month | 12.54 | 0.07 | 40.91 | (23.73) | 123.04 | |
| MLLCF | Molecular Partners AG | (0.18) | 9 per month | 0.00 | (0.12) | 0.00 | (3.61) | 48.13 | |
| SCNLF | Scancell Holdings plc | (0.18) | 9 per month | 0.00 | 0.03 | 0.00 | 0.00 | 16.67 | |
| BRIBF | Brii Biosciences Limited | (0.18) | 6 per month | 0.00 | (0.15) | 0.00 | 0.00 | 20.83 | |
| AAWH | Ascend Wellness Holdings | 0.00 | 0 per month | 9.25 | 0 | 12.24 | (15.22) | 76.16 | |
| JWCTF | JW Therapeutics Co | (0.18) | 22 per month | 0.00 | (0.12) | 0.00 | 0.00 | 20.00 | |
| HOFBF | Hofseth BioCare ASA | (0.18) | 14 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| KNTPF | Kintor Pharmaceutical Limited | (0.18) | 3 per month | 0.00 | 0.09 | 0.00 | 0.00 | 27.27 | |
| VMTHF | Venus Medtech | 0.05 | 6 per month | 0.00 | (0.21) | 0.00 | 0.00 | 10.00 |
Innate Pharma Additional Predictive Modules
Most predictive techniques to examine Innate price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Innate using various technical indicators. When you analyze Innate charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Innate Pharma Predictive Indicators
The successful prediction of Innate Pharma stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Innate Pharma, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Innate Pharma based on analysis of Innate Pharma hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Innate Pharma's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Innate Pharma's related companies.
Currently Active Assets on Macroaxis
Complementary Tools for Innate Pink Sheet analysis
When running Innate Pharma's price analysis, check to measure Innate Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Innate Pharma is operating at the current time. Most of Innate Pharma's value examination focuses on studying past and present price action to predict the probability of Innate Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Innate Pharma's price. Additionally, you may evaluate how the addition of Innate Pharma to your portfolios can decrease your overall portfolio volatility.
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |